GlassScriptPhysician profile
Michael David Saggio
NPI 1720602477
$1,758.32
in general payments reported to CMS, 2019-2025
18 companies · $144 in 2025
The $144 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,018 · 2023: $533 · 2024: $63.79 · 2025: $144.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $740.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $740.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Emd Serono, INC. | $256.13 | 2022-2023 | |
| Abbvie INC. | $229.91 | 2022 | |
| Idorsia Pharmaceuticals US INC | $202.85 | 2022-2023 | Quviviq |
| Jazz Pharmaceuticals INC. | $150.17 | 2023 | Epidiolex |
| Samsung Hme America, INC. | $144.00 | 2025 | |
| Teva Pharmaceuticals USA, INC. | $142.19 | 2022 | |
| Sk Life Science, INC. | $132.60 | 2022 | |
| Horizon Therapeutics Plc | $130.31 | 2022 | |
| Biogen, INC. | $115.11 | 2022-2023 | Spinraza |
| Neurelis, INC. | $76.86 | 2023 | Valtoco |
| Argenx US, INC. | $31.80 | 2023 | Vyvgart Hytrulo |
| Amgen INC. | $27.26 | 2024 | Uplizna |
| Azurity Pharmaceuticals, INC. | $23.33 | 2023 | Eprontia |
| Almatica Pharma LLC | $21.62 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $20.85 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $19.33 | 2024 | Vns Therapy Sentiva Model 1000 Generator |
| Pfizer INC. | $17.20 | 2024 | |
| Ironshore Pharmaceuticals INC. | $16.80 | 2023 | Jornay Pm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Saggio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.